HOUSTON, Sept. 30, 2022 /PRNewswire/ — PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, is ready to produce 20 million doses of the IndoVac COVID-19 vaccine this year and 100 million doses by 2024. Drs. Maria Elena Bottazzi and Peter Hotez at The Texas Children’s Hospital Center for Vaccine Development; ©2021 […]
The post TEXAS-DEVELOPED PATENT-FREE COVID-19 VACCINE TECHNOLOGY RECEIVES EMERGENCY USE AUTHORIZATION IN INDONESIA appeared first on The Black Chronicle.